| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
300,672,000 |
| Market
Cap: |
441.99(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.36 - $14.05 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 7.8 |
| Insider 6 Months : 7.8 |
| Insider 3/6 Months : 16 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Pacific Biosciences of California is a life science technology company that is designing, developing and manufacturing sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Co.'s products address solutions across a set of applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. Co. has developed HiFi long-read sequencing combined with Single Molecule Real-Time technology, which enables single-molecule, real-time detection of nucleic acid sequences for long-read applications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
40,000 |
40,000 |
40,000 |
40,000 |
| Total Buy Value |
$176,160 |
$176,160 |
$176,160 |
$176,160 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
192,570 |
243,582 |
436,886 |
654,669 |
| Total Sell Value |
$1,111,017 |
$1,552,073 |
$3,531,312 |
$5,254,296 |
| Total People Sold |
5 |
5 |
5 |
6 |
| Total Sell Transactions |
11 |
13 |
20 |
32 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mohr Marshall |
Director |
– • – |
2022-06-10 |
4 |
OE |
$1.83 |
$64,050 |
D/D |
35,000 |
60,000 |
|
- |
|
| Farmer Michele |
See Remarks |
• – – |
2022-05-18 |
4 |
S |
$5.55 |
$19,819 |
D/D |
(3,573) |
60,354 |
|
-12% |
|
| Ericson William W. |
Director |
– • – |
2022-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,268 |
1,336 |
|
- |
|
| Ericson William W. |
Director |
– • – |
2022-03-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,848,397) |
0 |
|
- |
|
| Farmer Michele |
See Remarks |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
62,500 |
|
- |
|
| Henry Christian O |
See Remarks |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
107,500 |
779,858 |
|
- |
|
| Fromen Peter |
See Remarks |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
190,280 |
|
- |
|
| Kim Susan G. |
See Remarks |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
174,966 |
|
- |
|
| Van Oene Mark |
See Remarks |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
72,500 |
366,020 |
|
- |
|
| Henry Christian O |
President & CEO |
• – – |
2022-02-17 |
4 |
S |
$11.09 |
$23,533 |
D/D |
(2,122) |
672,358 |
|
59% |
|
| Kim Susan G. |
Chief Financial Officer |
• – – |
2022-02-17 |
4 |
S |
$11.06 |
$11,746 |
D/D |
(1,062) |
134,966 |
|
59% |
|
| Ordonez Kathy |
Director |
– • – |
2022-02-16 |
4 |
S |
$11.50 |
$37,720 |
D/D |
(3,280) |
18,595 |
|
59% |
|
| Mohr Marshall |
Director |
– • – |
2022-01-14 |
4 |
OE |
$3.57 |
$89,250 |
D/D |
25,000 |
25,000 |
|
- |
|
| Fromen Peter |
Chief Commercial Officer |
• – – |
2022-01-11 |
4 |
S |
$14.30 |
$281,996 |
D/D |
(19,720) |
140,280 |
|
62% |
|
| Van Oene Mark |
Chief Operating Officer |
• – – |
2022-01-11 |
4 |
S |
$14.23 |
$590,260 |
D/D |
(41,480) |
293,520 |
|
62% |
|
| Kim Susan G. |
Chief Financial Officer |
• – – |
2021-09-29 |
4 |
S |
$25.75 |
$522,004 |
D/D |
(20,272) |
136,028 |
|
53% |
|
| Henry Christian O |
President & CEO |
• – – |
2021-09-16 |
4 |
S |
$26.91 |
$2,435,893 |
D/D |
(90,520) |
674,480 |
|
66% |
|
| Ericson William W. |
Director |
– • – |
2021-05-25 |
4 |
AS |
$25.88 |
$971,058 |
D/D |
(37,500) |
0 |
|
1% |
|
| Ericson William W. |
Director |
– • – |
2021-05-25 |
4 |
OE |
$1.83 |
$178,000 |
D/D |
37,500 |
37,500 |
|
- |
|
| Farmer Michele |
Chief Accounting Officer |
• – – |
2021-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
|
- |
|
| Hunkapiller Michael |
Director |
– • – |
2021-02-26 |
4 |
AS |
$30.69 |
$7,265,866 |
D/D |
(234,246) |
848,405 |
|
2% |
|
| Hunkapiller Michael |
Director |
– • – |
2021-02-26 |
4 |
OE |
$5.27 |
$1,490,207 |
D/D |
234,246 |
1,082,651 |
|
- |
|
| Hunkapiller Michael |
Director |
– • – |
2021-02-25 |
4 |
AS |
$31.05 |
$10,972,944 |
D/D |
(339,377) |
848,405 |
|
3% |
|
| Hunkapiller Michael |
Director |
– • – |
2021-02-25 |
4 |
OE |
$5.27 |
$2,172,291 |
D/D |
339,377 |
1,187,782 |
|
- |
|
| Hunkapiller Michael |
Director |
– • – |
2021-02-24 |
4 |
AS |
$35.59 |
$9,805,281 |
D/D |
(266,427) |
848,405 |
|
-8% |
|
239 Records found
|
|
Page 3 of 10 |
|
|
0.09 (6.52%) 
